- Previous Close
18.90 - Open
18.50 - Bid 18.67 x 40000
- Ask 18.77 x 29200
- Day's Range
18.43 - 18.78 - 52 Week Range
18.43 - 31.07 - Volume
3,296 - Avg. Volume
82,965 - Market Cap (intraday)
5.226B - Beta (5Y Monthly) 0.76
- PE Ratio (TTM)
17.31 - EPS (TTM)
1.08 - Earnings Date Feb 25, 2025
- Forward Dividend & Yield 0.71 (3.78%)
- Ex-Dividend Date Apr 11, 2025
- 1y Target Est
--
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations. In addition, the company offers crop protection and seed enhancement related solutions. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
www.croda.com6,027
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: COIHY
View MorePerformance Overview: COIHY
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COIHY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COIHY
View MoreValuation Measures
Market Cap
5.28B
Enterprise Value
5.97B
Trailing P/E
17.44
Forward P/E
18.48
PEG Ratio (5yr expected)
1.36
Price/Sales (ttm)
2.51
Price/Book (mrq)
1.79
Enterprise Value/Revenue
2.84
Enterprise Value/EBITDA
12.33
Financial Highlights
Profitability and Income Statement
Profit Margin
9.73%
Return on Assets (ttm)
4.09%
Return on Equity (ttm)
6.84%
Revenue (ttm)
1.63B
Net Income Avi to Common (ttm)
158.5M
Diluted EPS (ttm)
1.08
Balance Sheet and Cash Flow
Total Cash (mrq)
166.8M
Total Debt/Equity (mrq)
30.44%
Levered Free Cash Flow (ttm)
122.56M